Diphyllin heterocyclic derivative as well as preparation method and application thereof

A technology of basil and its derivatives, applied in the fields of medicinal chemistry and pharmacology, can solve the problems of poor stability of glycosidic bond metabolism, complex chemical synthesis, inactivation of glycosidase hydrolysis, etc., and achieve strong tumor cell proliferation inhibitory activity Effect

Active Publication Date: 2020-05-19
NANTONG UNIVERSITY
View PDF2 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the chemical synthesis of glycoside compounds is relatively complicated, and the metabolic stabilit

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Diphyllin heterocyclic derivative as well as preparation method and application thereof
  • Diphyllin heterocyclic derivative as well as preparation method and application thereof
  • Diphyllin heterocyclic derivative as well as preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0033] Dissolve 114mg (0.3mmol) of kaempferol in 3mL of DMF, add 282mg (1.5mmol) of 1,2-dibromoethane and 248mg (1.8mmol) of anhydrous potassium carbonate, and react at room temperature for 6h. TLC detected the end of the reaction, added 30mL of ethyl acetate to dilute, then washed with water and saturated brine successively, MgSO 4 Drying, drying under reduced pressure, column chromatography (prtroleum ether:EtOAc=3:1, R f =0.3) to obtain 100 mg of pale yellow solid. Dissolve the solid in 3ml of DMF, add 200mg (2mmol) of N-methylpiperazine and 552mg (4mmol) of anhydrous potassium carbonate, react at 120°C for 2h, monitor the end of the reaction by TLC, add 20ml of ethyl acetate to dilute , and then washed successively with water, saturated brine, MgSO 4 Drying, drying under reduced pressure, column chromatography (DCM:MeOH=30:1, R f = 0.2) 83 mg of 4-O-[2'-(N-methylpiperazinyl)-ethyl]-sinifolin (2a) was obtained as a pale yellow solid (55% yield in two steps).

[0034] Fo...

Embodiment 2-5

[0036] Example compounds were prepared according to the method of Example 1 above.

[0037] Listed below are the physicochemical data of each compound of 2b-2f:

[0038] 2b: 1 H NMR (400MHz, CDCl 3 )δ: 7.58(s,1H,ArH),7.06(s,1H,ArH),6.96(d,J=7.9Hz,1H,ArH),6.80(m,2H,ArH),6.07(dd,J= 18.0, 1.3Hz, 2H, OCH 2 O),5.50(s,2H,ArCH 2 O), 4.33(t, J=5.6Hz, 2H, OCH 2 ),4.07(s,3H,OCH 3 ),3.81(s,3H,OCH 3 ),3.76(m,1H,CH),2.93(m,2H,NCH 2 ), 2.90(t, J=5.7Hz, 2H, NCH 2 ),2.36(m,2H,NCH 2 ),1.95(m,2H,CH 2 ),1.64(m,2H,CH 2 ); 13 C NMR (100MHz, CDCl 3)δ: 169.7, 151.5, 150.2, 147.5, 147.4, 146.9, 134.7, 130.6, 128.4, 126.5, 125.9, 123.6, 119.2, 110.7, 108.2, 106.1, 101.2, 100.6, 75.6, 66.7, 58.0, ,34.4.HRMS(ESI):m / z calcd for C 28 h 3 o 8 N:508.1969; found:508.1966[M+H] + .

[0039] 2c: 1 H NMR (400MHz, Chloroform-d) δ: 7.55(s,1H,ArH),7.06(s,1H,ArH),6.96(d,J=7.9Hz,1H,ArH),6.80(m,2H,ArH) ), 6.07 (d, J=18.0Hz, 2H, OCH 2 O),5.49(s,2H,ArCH 2 O), 4.25(t, J=6.4Hz, 2H, OCH 2 ),4.06(s,3...

experiment example 1

[0044] Drug Experiment Example 1: Test of the Cytotoxic Activity of Compounds 2a-2f and Paclitaxel on Human Esophageal Cancer Cells (TE-13)

[0045] Human esophageal cancer cells TE-13 were cultured with RPMI1640 medium containing 10% fetal bovine serum, 100 U / mL penicillin and 100 U / mL streptomycin. cells in 5×10 per well 3 concentration into a 96-well plate at 37 °C with 5% CO 2 Incubate for 24 hours in a moist air incubator.

[0046] Compounds 2a-2f were dissolved in DMSO to prepare 1×10 -2 mol / L mother solution, dilute the mother solution to the corresponding concentration with complete medium, inoculate the cells in the logarithmic growth phase on a 96-well plate, add different concentrations of compound solutions after 24 hours of attachment, set 4 parallel wells for each concentration, and culture for 68 hours Then add tetramethyl azolium salt (MTT) solution, continue to cultivate for 4 hours, discard the culture medium, add 150 μL of dimethyl sulfoxide, shake for 10...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention belongs to the technical field of medicinal chemistry and pharmacology, and relates to a diphyllin heterocyclic derivative as well as a preparation method and application thereof. The diphyllin heterocyclic derivative has a chemical structural formula shown as a formula (I), is of a non-glucoside structure and has metabolic stability superior to that of glucoside compounds. These derivatives are found to have strong activity of inhibiting tumor cell growth, and can be expected to be used as antitumor drugs.

Description

technical field [0001] The invention belongs to the technical field of medicinal chemistry and pharmacology, and in particular relates to a basilicin heterocyclic derivative and a preparation method and application thereof. Background technique [0002] With the advancement of medicine, common infectious diseases are gradually being controlled, and malignant tumor-cancer has become one of the main diseases that are common and seriously threaten human life and quality of life. Plant-derived antitumor drugs play an important role in clinical treatment. In recent years, studies have found that the xyloside Cleistanthin-A and the quinoloside Patentiflorin A of the natural lignan kaempferin have strong anti-tumor activity. However, the chemical synthesis of glycoside compounds is relatively complicated, and the metabolic stability of glycosidic bonds is not good, and they are easily hydrolyzed and inactivated by endogenous glycosidases. [0003] Contents of the invention ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C07D405/14C07D407/04A61P35/00
CPCC07D405/14C07D407/04A61P35/00
Inventor 赵育沈卫东包小峰朱力
Owner NANTONG UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products